title: The Food and Drug Administration and varenicline: should risk communication be improved?
authors: Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.|School of Social and Community Medicine, University of Bristol, Bristol, UK.
authors: Neil M
authors: NM
authors: Davies
authors: School of Social and Community Medicine, University of Bristol, Bristol, UK.
authors: Kyla H
authors: KH
authors: Thomas
mesh_terms: D004348:Drug Labeling / Q000379:methods*; D058015:Health Communication / Q000379:methods*; D006801:Humans; D018722:Nicotinic Agonists / Q000009:adverse effects*; D012306:Risk; D014481:United States; D014486:United States Food and Drug Administration; D000068580:Varenicline / Q000009:adverse effects*
chemical_list: D018722:Nicotinic Agonists; D000068580:Varenicline
keywords: Adverse drug reactions; evidence based medicine; hierarchy of evidence; nicotine replacement therapy; regulation; varenicline